Cargando…
Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab
BACKGROUND: Paraneoplastic hyper-eosinophilia associated with metastatic lung adenocarcinoma is a rare finding and has been associated with a poor prognosis when present. Early hyper-eosinophilia appearing following non-small cell lung cancer (NSCLC) treatment with immune checkpoint inhibitors (ICI)...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327228/ https://www.ncbi.nlm.nih.gov/pubmed/34377046 http://dx.doi.org/10.1177/11795484211030164 |
_version_ | 1783732028814917632 |
---|---|
author | Wehbe, Hisham Kozah, Maria Koubaissi, Salwa A |
author_facet | Wehbe, Hisham Kozah, Maria Koubaissi, Salwa A |
author_sort | Wehbe, Hisham |
collection | PubMed |
description | BACKGROUND: Paraneoplastic hyper-eosinophilia associated with metastatic lung adenocarcinoma is a rare finding and has been associated with a poor prognosis when present. Early hyper-eosinophilia appearing following non-small cell lung cancer (NSCLC) treatment with immune checkpoint inhibitors (ICI) has been previously reported with contradictory outcomes. CASE SUMMARY: We present the case of an elderly man with newly diagnosed metastatic lung adenocarcinoma and baseline hyper-eosinophilia, treated with pembrolizumab, and showing evidence of significant and rapid disease progression suggestive of hyper-progressive disease, worsening baseline hyper-eosinophilia, and a fatal outcome within 1 month of therapy initiation. CONCLUSION: Pre-treatment hyper-eosinophilia could represent a predictive factor of an unfavorable response to ICI treatment in cases of NSCLC. Additional similar cases are needed to draw a more conclusive relationship. |
format | Online Article Text |
id | pubmed-8327228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-83272282021-08-09 Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab Wehbe, Hisham Kozah, Maria Koubaissi, Salwa A Clin Med Insights Circ Respir Pulm Med Case Report BACKGROUND: Paraneoplastic hyper-eosinophilia associated with metastatic lung adenocarcinoma is a rare finding and has been associated with a poor prognosis when present. Early hyper-eosinophilia appearing following non-small cell lung cancer (NSCLC) treatment with immune checkpoint inhibitors (ICI) has been previously reported with contradictory outcomes. CASE SUMMARY: We present the case of an elderly man with newly diagnosed metastatic lung adenocarcinoma and baseline hyper-eosinophilia, treated with pembrolizumab, and showing evidence of significant and rapid disease progression suggestive of hyper-progressive disease, worsening baseline hyper-eosinophilia, and a fatal outcome within 1 month of therapy initiation. CONCLUSION: Pre-treatment hyper-eosinophilia could represent a predictive factor of an unfavorable response to ICI treatment in cases of NSCLC. Additional similar cases are needed to draw a more conclusive relationship. SAGE Publications 2021-07-31 /pmc/articles/PMC8327228/ /pubmed/34377046 http://dx.doi.org/10.1177/11795484211030164 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Wehbe, Hisham Kozah, Maria Koubaissi, Salwa A Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab |
title | Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab |
title_full | Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab |
title_fullStr | Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab |
title_full_unstemmed | Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab |
title_short | Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab |
title_sort | lung adenocarcinoma with paraneoplastic hyper-eosinophilia not responding to pembrolizumab |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327228/ https://www.ncbi.nlm.nih.gov/pubmed/34377046 http://dx.doi.org/10.1177/11795484211030164 |
work_keys_str_mv | AT wehbehisham lungadenocarcinomawithparaneoplastichypereosinophilianotrespondingtopembrolizumab AT kozahmaria lungadenocarcinomawithparaneoplastichypereosinophilianotrespondingtopembrolizumab AT koubaissisalwaa lungadenocarcinomawithparaneoplastichypereosinophilianotrespondingtopembrolizumab |